Log in to save to my catalogue

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2067108382

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

About this item

Full title

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2018-07, Vol.24 (7), p.939-946

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

CRISPR/Cas9 has revolutionized our ability to engineer genomes and conduct genome-wide screens in human cells
1

3
. Whereas some cell types are amenable to genome engineering, genomes of human pluripotent stem cells (hPSCs) have been difficult to engineer, with reduced efficiencies relative to tumour cell lines or mouse embryonic stem...

Alternative Titles

Full title

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2067108382

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2067108382

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0050-6

How to access this item